Home › Female Infertility › NCT06141135

GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial

Who can join

Ages 35 to 40 · Women

Inclusion Criteria:

* Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
* Utilization of Intracytoplasmic Sperm Injection ICSI (recommended) or ---Traditional IVF
* Utilization of ejaculated or testicular sperm
* Utilization of autologous or donor sperm
* All Controlled Ovarian Hyperstimulation (COH) protocols

Exclusion Criteria:

* Utilization of donor oocytes
* Utilization of gestational carrier
* Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages
* Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers
* Preimplantation genetic testing for monogenic/single gene disorders (PGT-M)
* Translocation carriers

About the study

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

What is being tested

• Preimplantation genetic testing for aneuploidy (PGTA) (other)

Sponsor: Genomic Prediction Inc. · Participants: 240 · Started: Nov 15, 2023

Contact the study team

• Talia Metzgar · Phone: (973) 529- 4223
• Kristin Rooney · Phone: (781) 434-6500

Official record on ClinicalTrials.gov — NCT06141135

Locations in the U.S.

Conditions

• Female Infertility

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.